Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.34M Buy
9,222
+1,018
+12% +$348K 2% 19
2026
Q1
$2.89M Buy
8,204
+17
+0.2% +$6.06K 1.95% 21
2025
Q4
$2.68M Sell
8,187
-194
-2% -$61.5K 1.77% 21
2025
Q3
$2.37M Buy
8,381
+549
+7% +$159K 1.55% 30
2025
Q2
$2.19M Buy
7,832
+321
+4% +$90.9K 1.7% 30
2025
Q1
$2.34M Sell
7,511
-228
-3% -$67.3K 1.85% 21
2024
Q4
$2.02M Buy
+7,739
New +$2.3M 1.52% 31

Other funds holding AMGN

U.S. Wealth Group's AMGN Position: Q2 2026 in Review

U.S. Wealth Group increased its Amgen (AMGN) stake by 12% in Q2 2026, buying an estimated $348K and bringing the position to 9,222 shares worth $3.34M. The position accounts for 2% of the portfolio, ranked #19.

U.S. Wealth Group first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. 3,153 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • U.S. Wealth Group held 9,222 shares of Amgen worth $3.34M as of Q2 2026.
  • U.S. Wealth Group bought 1,018 Amgen shares in Q2 2026, an estimated $348K.
  • Amgen made up 2% of U.S. Wealth Group's portfolio in Q2 2026, its #19 holding.
  • U.S. Wealth Group first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
  • 3,153 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on U.S. Wealth Group's 13F filing for Q2 2026, filed 10 Sep 2026.